Crossmark

Modifiable dementia risk score to study heterogeneity in treatment effect of a dementia prevention trial: a post hoc analysis in the preDIVA trial using the LIBRA index

Crossref DOI link: https://doi.org/10.1186/s13195-018-0389-4

Published Online: 2018-06-30

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

van Middelaar, Tessa http://orcid.org/0000-0002-5421-2610
Hoevenaar-Blom, Marieke P.

van Gool, Willem A.

Moll van Charante, Eric P.

van Dalen, Jan-Willem

Deckers, Kay

Köhler, Sebastian

Richard, Edo
Funding

Funding for this research was provided by:

Ministerie van Volksgezondheid, Welzijn en Sport (50-50110-98-020)

Innovatiefonds Zorgverzekeraars (05-234)

ZonMw (62000015, 733051041)

FP7 Health (305374)

Academy of Finland (291803)

Agence Nationale de la Recherche (ANR-14-JPPS-0001-02)

Bundesministerium für Bildung und Forschung (FKZ01ED1509)

Vetenskapsrådet (529-2014-7503)
License Information

Text and Data Mining valid from 2018-06-30
More Information

Article History

Received: 8 February 2018

Accepted: 27 May 2018

First Online: 30 June 2018

Ethics approval and consent to participate

: The medical ethics committee of the Academic Medical Center approved the trial (project number 05/093) and all participants gave written informed consent.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below